Five Stocks To Buy: Jio Financial Services, Tata Chemicals, Dr. Reddy’s Laboratories – A Detailed Analysis

In today’s fast-paced stock market, it’s essential to stay informed about the latest analyst recommendations and expert insights. In this article, we’ll dive into five stocks that have received analyst buy calls, including Jio Financial Services, Tata Chemicals, Ircon International, PI Industries, and Dr. Reddy’s Laboratories.

Jio Financial Services – A Buy Call with Upside Potential

Jio Financial Services Ltd. has been recommended as a buy by Aamar Deo Singh, Sr. Vice President, Research at Angel One Ltd. The target price is Rs 343, with a stop loss at Rs 297, implying an upside of 8.89%. The only analyst tracking the company, according to Bloomberg data, has a 12-month analysts’ consensus target price of Rs 325, implying a 1.2% upside.

Tata Chemicals – A Buy Call with Potential for Upside

Tata Chemicals Ltd. has also received a buy call from Angel One Ltd., with a target price of Rs 1,039 and a stop loss at Rs 947, implying an upside of 6.02%. However, one out of eight analysts tracking the company have a ‘buy’ rating, one recommend a ‘hold’, and six suggest a ‘sell’, according to Bloomberg data. The 12-month analysts’ consensus target price on the stock is Rs 861, implying a downside of 13%.

Ircon International – A Buy Call with Potential for Upside

Ircon International Ltd. has been recommended as a buy by Nilesh Jain, Head VP Technical & Derivatives Research at Centrum Broking Ltd. The target price is Rs 190, with a stop loss at Rs 176, implying an upside of 5.56%. Two out of three analysts tracking the company have a ‘sell’ rating, one recommends a ‘hold’, according to Bloomberg data. The 12-month analysts’ consensus target price on the stock is Rs 166, implying a downside of 8.3%.

PI Industries – A Buy Call with Potential for Upside

PI Industries Ltd. has also received a buy call from Centrum Broking, with a target price of Rs 4451 and a stop loss at Rs 4150, implying an upside of 4.75%. Thirteen out of 27 analysts tracking the company have a ‘buy’ rating, seven recommend a ‘hold’, and seven suggest a ‘sell’, according to Bloomberg data. The 12-month analysts’ consensus target price on the stock is Rs 4,078, implying a downside of 4%.

Dr. Reddy’s Laboratories – A Buy Call with Potential for Upside

Dr. Reddy’s Laboratories Ltd. has been recommended as a buy by Rajesh Palviya, Technical and Derivatives Research at Axis Securities, with a target price of Rs 1345 and a stop loss at Rs 1270, implying an upside of 3.54%. Fifteen out of 39 analysts tracking the company have a ‘buy’ rating, 11 recommend a ‘hold’, and 14 suggest a ‘sell’, according to Bloomberg data. The 12-month analysts’ consensus target price on the stock is Rs 1,301, implying a upside of 1%.

Conclusion

In conclusion, these five stocks have received analyst buy calls, offering potential upside for investors. However, it’s essential to do your own research and consider the risks involved before making any investment decisions. Remember to always set stop loss and target prices to manage your risk and maximize your returns.